Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Retained Earnings (2020 - 2025)

Rapid Micro Biosystems' Retained Earnings history spans 6 years, with the latest figure at -$522.4 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 9.91% to -$522.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$522.4 million, a 9.91% decrease, with the full-year FY2025 number at -$522.4 million, down 9.91% from a year prior.
  • Retained Earnings hit -$522.4 million in Q4 2025 for Rapid Micro Biosystems, down from $12000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for RPID hit a ceiling of $83000.0 in Q3 2024 and a floor of -$522.4 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$259.9 million across 5 years, with a median of -$330.0 million in 2022.
  • The widest YoY moves for Retained Earnings: up 100.02% in 2024, down 470468.32% in 2024.
  • Tracing RPID's Retained Earnings over 5 years: stood at -$16000.0 in 2021, then plummeted by 6831.25% to -$1.1 million in 2022, then skyrocketed by 90.89% to -$101000.0 in 2023, then crashed by 470468.32% to -$475.3 million in 2024, then dropped by 9.91% to -$522.4 million in 2025.
  • Business Quant data shows Retained Earnings for RPID at -$522.4 million in Q4 2025, $12000.0 in Q3 2025, and -$498.4 million in Q2 2025.